Merck & Company Inc - Other Cashflows From Financing Activities

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Cashflows-From-Financing-Activities" stands at -4.05 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2022.

Merck & Company Inc's third quarter result of -3.80 Billion USD for the item "Other Cashflows From Financing Activities" represents a decrease of -1,986.26 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of -3.80 Billion USD for the item "Other Cashflows From Financing Activities" represents a decrease of -13,962.96 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of -4.05 Billion USD for the item "Other Cashflows From Financing Activities" represents a decrease of -1,346.43 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an decrease of -15.46 Billion United States Dollars compared to the value the year prior.
The 1 year change is -15.46 Billion United States Dollars.
The 3 year change is -5.00 Billion United States Dollars.
The 5 year change is -3.87 Billion United States Dollars.
The 10 year change is -4.74 Billion United States Dollars.

The Serie's long term average value is 1.26 Billion United States Dollars. It's latest available value, on 09/30/2025, is -5.31 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is +1.86 Billion.
The Serie's change in United States Dollars from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -15.49 Billion.